Amgen Inc (WBO:AMGN) Stock News, Headlines & Updates
Amgen Inc Stock News from GuruFocus
- 1
Jul 01, 2024
Amgen Inc: An Exploration into Its Intrinsic Value
GuruFocus Research ā¢ 6:00am
Jun 17, 2024
Unlocking Intrinsic Value: Analysis of Amgen Inc
GuruFocus Research ā¢ 6:00am
Jun 14, 2024
FDA APPROVES BLINCYTOĀ® (BLINATUMOMAB) IN CD19-POSITIVE PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) IN THE CONSOLIDATION PHASE
PRNewswire ā¢ 4:00pm
Jun 12, 2024
AMGEN TO PRESENT INNOVATIVE RHEUMATOLOGY RESEARCH AT EULAR 2024
PRNewswire ā¢ 9:00am
Jun 05, 2024
AMGEN TO PRESENT AT GOLDMAN SACHS 45TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
PRNewswire ā¢ 4:00pm
AMGEN ANNOUNCES POSITIVE RESULTS FOR PHASE 3 REGISTRATIONAL TRIAL EVALUATING UPLIZNAĀ® (INEBILIZUMAB-CDON) FOR TREATMENT OF IMMUNOGLOBULIN G4-RELATED DISEASE (IgG4-RD)
PRNewswire ā¢ 9:00am
Jun 03, 2024
AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE
PRNewswire ā¢ 4:00pm
Beyond Market Price: Uncovering Amgen Inc's Intrinsic Value
GuruFocus Research ā¢ 6:00am
May 20, 2024
The Art of Valuation: Discovering Amgen Inc's Intrinsic Value
GuruFocus Research ā¢ 6:00am
May 19, 2024
NEW DATA PRESENTED AT ATS 2024 SHOW THE POTENTIAL OF TEZSPIREĀ® TO HELP PATIENTS LIVING WITH COPD
PRNewswire ā¢ 5:00pm
May 16, 2024
FDA APPROVES IMDELLTRAā¢ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER
PRNewswire ā¢ 6:00pm
May 15, 2024
AMGEN TO HOST CONFERENCE CALL FOLLOWING ATS 2024
PRNewswire ā¢ 6:00pm
Amgen Inc's Dividend Analysis
GuruFocus Research ā¢ 5:01am
May 09, 2024
AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE
PRNewswire ā¢ 4:00pm
May 06, 2024
The Art of Valuation: Discovering Amgen Inc's Intrinsic Value
GuruFocus Research ā¢ 6:00am
May 04, 2024
Unveiling Amgen (AMGN)'s Value: Is It Really Priced Right? A Comprehensive Guide
GuruFocus Research ā¢ 12:32am
Decoding Amgen Inc (AMGN): A Strategic SWOT Insight
GuruFocus Research ā¢ 11:03pm
May 03, 2024
Amgen Inc (AMGN) Q1 2024 Earnings Call Transcript Highlights: Strong Growth and Strategic Advances
GuruFocus Research ā¢ 1:57am
Q1 2024 Amgen Inc Earnings Call Transcript
GuruFocus Research ā¢ 11:22pm
May 02, 2024
Amgen Inc (AMGN) Q1 2024 Earnings: Aligns with EPS Projections Amid Revenue Growth and Challenges
GuruFocus Research ā¢ 3:42pm
May 01, 2024
AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024
PRNewswire ā¢ 7:01am
Apr 29, 2024
AMGEN ANNOUNCES WEBCAST OF 2024 FIRST QUARTER FINANCIAL RESULTS
PRNewswire ā¢ 4:00pm
Apr 26, 2024
AMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCY
PRNewswire ā¢ 9:00am
Apr 16, 2024
AMGEN TO PRESENT TEZSPIREĀ® PHASE 2A COPD DATA AT ATS 2024
PRNewswire ā¢ 5:00pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news